NextTrip (NTRP) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 11, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-38015
Entity Registrant Name	SIGMA ADDITIVE SOLUTIONS, INC.
Entity Central Index Key	0000788611
Entity Tax Identification Number	27-1865814
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3900 Paseo del Sol
Entity Address, City or Town	Santa Fe
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	87507
City Area Code	(505)
Local Phone Number	438-2576
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SASI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,498,802

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 4,800,680	$ 11,447,047
Accounts Receivable, net	367,770	412,192
Inventory	967,432	710,080
Prepaid Assets	177,724	114,278
Total Current Assets	6,313,606	12,683,597
Other Assets:
Property and Equipment, net	244,838	232,282
Intangible Assets, net	1,084,205	925,111
Total Other Assets	1,329,043	1,157,393
TOTAL ASSETS	7,642,649	13,840,990
Current Liabilities:
Accounts Payable	403,547	206,442
Deferred Revenue	129,689	148,855
Accrued Expenses	287,645	625,942
Total Current Liabilities	820,881	981,239
TOTAL LIABILITIES	820,881	981,239
Stockholders’ Equity
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 465 shares issued and outstanding	1	1
Common Stock, $0.001 par value; 24,000,000 shares authorized; 10,498,802 shares issued and outstanding	10,499	10,499
Additional Paid-In Capital	54,193,981	53,442,431
Accumulated Deficit	(47,382,713)	(40,593,180)
Total Stockholders’ Equity	6,821,768	12,859,751
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 7,642,649	$ 13,840,990

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	465	465
Preferred stock, shares outstanding	465	465
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	24,000,000	24,000,000
Common stock, shares issued	10,498,802	10,498,802
Common stock, shares outstanding	10,498,802	10,498,802

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
REVENUES	$ 188,245	$ 700,237	$ 476,749	$ 1,302,525
COST OF REVENUE	79,713	164,766	312,879	409,493
GROSS PROFIT	108,532	535,471	163,870	893,032
OPERATING EXPENSES:
Salaries & Benefits	1,227,805	1,222,760	3,704,633	3,055,279
Stock-Based Compensation	275,418	659,512	613,833	893,431
Operations and R&D Costs	152,245	131,772	442,548	608,812
Investor, Public Relations and Marketing	46,832	119,622	293,458	342,725
Organization Costs	140,522	342,112	260,088	578,256
Legal & Professional Service Fees	252,886	261,075	608,830	681,941
Office Expenses	183,608	172,238	692,640	472,335
Depreciation & Amortization	26,857	27,689	88,302	76,502
Other Operating Expenses	86,783	90,108	263,747	267,663
Total Operating Expenses	2,392,956	3,026,888	6,968,079	6,976,944
LOSS FROM OPERATIONS	(2,284,424)	(2,491,417)	(6,804,209)	(6,083,912)
OTHER INCOME (EXPENSE)
Interest Income	278	2,981	3,025	10,053
State Incentives			76,628
Exchange Rate Loss	(6,184)	(490)	(16,950)	(333)
Interest Expense	(1,978)	(2,052)	(5,367)	(5,434)
Other Income				1,092,441
Total Other Income (Expense)	(7,884)	439	57,336	1,096,727
LOSS BEFORE PROVISION FOR INCOME TAXES	(2,292,308)	(2,490,978)	(6,746,873)	(4,987,185)
Provision for income Taxes
Net Loss	(2,292,308)	(2,490,978)	(6,746,873)	(4,987,185)
Preferred Dividends	(14,220)	(14,220)	(42,660)	(89,347)
Net Loss Applicable to Common Stockholders	$ (2,306,528)	$ (2,505,198)	$ (6,789,533)	$ (5,076,532)
Net Loss per Common Share – Basic and Diluted	$ (0.22)	$ (0.24)	$ (0.65)	$ (0.53)
Weighted Average Number of Shares Outstanding – Basic and Diluted	10,498,802	10,494,560	10,498,802	9,602,666

Statement of Stockholders' Equi

Statement of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 1	$ 5,995	$ 38,262,744	$ (33,105,008)	$ 5,163,732
Begining balance, shares at Dec. 31, 2020	715	5,995,320
Net Loss				(4,987,185)	(4,987,185)
Preferred Stock Dividends		$ 19	89,328	(89,347)
Preferred Stock Dividends, shares		19,000
Stock Options Awarded to Directors			404,580		404,580
Stock Options Awarded to Employees		$ 5	893,426		893,431
Stock Options Awarded to Employees, shares		5,204
Securities Issued for Third Party Services		$ 2	128,807		128,809
Securities Issued for Third Party Services, shares		1,500
Common Shares Sold in Public Offerings		$ 3,902	14,865,997		14,869,899
Common Shares Sold in Public Offerings, shares		3,901,783
Extinguishment of Derivative Liability			(1,092,441)		(1,092,441)
Common Shares Issued Upon Conversion of Preferred Shares		$ 100	(100)
Common Shares Issued Upon Conversion of Preferred Shares, shares	(250)	100,000
Common Shares issued for Exercise of Common Warrants		$ 476	1,135,534		1,136,010
Common Shares issued for Exercise of Common Warrants, shares		475,995
Offering Costs			(1,600,967)		(1,600,967)
Ending balance, value at Sep. 30, 2021	$ 1	$ 10,499	53,086,908	(38,181,540)	14,915,868
Ending balance, shares at Sep. 30, 2021	465	10,498,802
Beginning balance, value at Jun. 30, 2021	$ 1	$ 10,494	52,058,003	(35,676,342)	16,392,156
Begining balance, shares at Jun. 30, 2021	465	10,493,598
Net Loss				(2,490,978)	(2,490,978)
Preferred Stock Dividends			14,220	(14,220)
Stock Options Awarded to Employees		$ 5	659,507		659,512
Stock Options Awarded to Employees, shares		5,204
Shares Securities Issued to Directors for Services			282,306		282,306
Securities Issued for Third Party Services			72,872		72,872
Securities Issued for Third Party Services, shares
Ending balance, value at Sep. 30, 2021	$ 1	$ 10,499	53,086,908	(38,181,540)	14,915,868
Ending balance, shares at Sep. 30, 2021	465	10,498,802
Beginning balance, value at Dec. 31, 2021	$ 1	$ 10,499	53,442,431	(40,593,180)	12,859,751
Begining balance, shares at Dec. 31, 2021	465	10,498,802
Net Loss				(6,746,873)	(6,746,873)
Preferred Stock Dividends			42,660	(42,660)
Stock Options Issued for Third Party Services			24,463		24,463
Stock Options Awarded to Directors			70,594		70,594
Stock Options Awarded to Employees			613,833		613,833
Stock Options Awarded to Employees, shares
Ending balance, value at Sep. 30, 2022	$ 1	$ 10,499	54,193,981	(47,382,713)	6,821,768
Ending balance, shares at Sep. 30, 2022	465	10,498,802
Beginning balance, value at Jun. 30, 2022	$ 1	$ 10,499	53,876,218	(45,076,185)	8,810,533
Begining balance, shares at Jun. 30, 2022	465	10,498,802
Net Loss				(2,292,308)	(2,292,308)
Preferred Stock Dividends			14,220	(14,220)
Preferred Stock Dividends, shares
Stock Options Issued for Third Party Services			973		973
Stock Options Awarded to Directors			27,152		27,152
Stock Options Awarded to Employees			275,418		275,418
Stock Options Awarded to Employees, shares
Ending balance, value at Sep. 30, 2022	$ 1	$ 10,499	$ 54,193,981	$ (47,382,713)	$ 6,821,768
Ending balance, shares at Sep. 30, 2022	465	10,498,802

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES
Net Loss	$ (6,746,873)	$ (4,987,185)
Noncash Expenses:
Depreciation and Amortization	88,302	76,502
Gain on Derivative Liability		(1,092,441)
Stock-Based Compensation - Employees	613,833	893,431
Stock-Based Compensation - Third Party Services	24,463	128,809
Stock-Based Compensation - Directors	70,594	404,580
Change in Assets and Liabilities:
Accounts Receivable	44,422	(335,178)
Inventory	(257,352)	(196,896)
Prepaid Assets	(63,446)	(13,940)
Accounts Payable	197,105	94,220
Deferred Revenue	(19,166)	7,523
Accrued Expenses	(338,297)	233,985
NET CASH USED IN OPERATING ACTIVITIES	(6,386,415)	(4,786,590)
INVESTING ACTIVITIES
Purchase of Property and Equipment	(83,848)	(116,631)
Purchase of Intangible Assets	(176,104)	(138,141)
NET CASH USED IN INVESTING ACTIVITIES	(259,952)	(254,772)
FINANCING ACTIVITIES
Gross Proceeds from Public and Private Issuances of Securities		14,869,899
Less Offering Costs		(1,600,967)
Proceeds from Exercise of Warrants		1,136,010
NET CASH PROVIDED BY FINANCING ACTIVITIES		14,404,942
NET CHANGE IN CASH FOR PERIOD	(6,646,367)	9,363,580
CASH AT BEGINNING OF PERIOD	11,447,047	3,700,814
CASH AT END OF PERIOD	4,800,680	13,064,394
Noncash Investing and Financing Activities Disclosure:
Issuance of Common Shares for Preferred Dividends		89,347
Other Noncash Operating Activities Disclosure:
Issuance of Securities for services	95,057	533,387
Disclosure of Cash Paid for:
Interest	5,367	5,434
Income Taxes

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 1 - Summary of Significant Accounting Policies Nature of Business Basis of Presentation Reclassification Fair Value of Financial Instruments The Company does not use derivative instruments for hedging of market risk or for trading or speculative purposes. On March 26, 2021, the Company issued warrants to purchase an aggregate of 2,190,000 May 24, 2021 12,000,000 24,000,000 May 24, 2023 Pursuant to ASC 815.40.25.10, such warrants were accounted for as a derivative liability because the Company did not have sufficient authorized and unissued shares of common stock available to settle the warrants at the issue date. On May 24, 2021, upon receiving stockholder approval to increase its authorized common shares, the Company reclassified the warrant liability to equity pursuant to ASC 815.40.35.8. For the nine months ended September 30, 2021, the Company recorded a gain of $ 1,092,441 Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share September 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,784,942 1,400,407 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,759,641 5,512,821 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2022 and 2021: Schedule of Computing Loss Per Share 2022 2021 2022 2021 Three Months Ended September 30 Nine Months Ended September 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.24 ) $ (0.65 ) $ (0.53 ) Loss Applicable to Common Stockholders (numerator) $ (2,306,528 ) $ (2,505,198 ) $ (6,789,533 ) $ (5,076,532 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,498,802 10,494,560 10,498,802 9,602,666 Accounting Estimates Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers, pursuant to which it leases its PrintRite3D platform for terms between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment to which customers have the right to substantially all the economic benefit from and exclusive right to use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The leases may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months with 30-days written notice. Some, but not all, of the leases permit lessees to purchase the equipment at any time at an amount that approximates fair value and are not reasonably certain to be exercised at the inception of the lease. There are no anticipated variable lease payments at the inception of the lease. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training. The Company has elected the single component practical expedient to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training component does not have the same pattern of transfer; therefore, this component is not eligible for the single component practical expedient. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased equipment based on its useful life, and the ability to refurbish and sell the equipment, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from these operating leases for the three and nine months ended September 30, 2022 was $ 2,834 17,006 Minimum Lease Payments Receivable Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 8,503 2023 $ 8,503 2024 - 2025 and thereafter - Total $ 17,006 Equipment Underlying Operating Leases: Equipment under operating leases as of September 30, 2022 were comprised of the following: Schedule of Assets underlying Operating Leases September 30, PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 4,173 Net Book Value $ 34,776 The Company is depreciating the underlying equipment over its useful life of 7

Inventory

Inventory	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventory	NOTE 2 – Inventory At September 30, 2022 and December 31, 2021, the Company’s inventory was comprised of the following: Schedule of Inventory September 30, December 31, Raw Materials $ 264,558 $ 202,015 Work in Process 420,420 224,079 Finished Goods 282,454 283,986 Total Inventory $ 967,432 $ 710,080

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 3 – Intangible Assets The Company’s intangible assets consist of patents and patent applications. Provisional patent applications are not amortized until a patent has been granted. Once a patent is granted, the Company will amortize the related costs over the estimated useful life of the patent. If a patent application is denied, then the costs will be expensed at that time. During 2022, $ 126,231 The following is a summary of definite-life intangible assets less accumulated amortization as of September 30, 2022 and December 31, 2021, respectively: Summary of Definite-life Intangible Assets and Accumulated Amortization September 30, December 31, Provisional Patent Applications $ 725,164 $ 675,291 Patents 426,601 300,370 Less: Accumulated Amortization (67,560 ) (50,550 ) Net Intangible Assets $ 1,084,205 $ 925,111 Amortization expense on intangible assets was $ 17,010 22,998 The estimated aggregate amortization expense for each of the following years ending December 31 is as follows: Schedule of Aggregate Amortization Expense 2022 (Remaining) $ 6,153 2023 24,610 2024 24,610 2025 24,610 Thereafter 279,058 Intangible asset and amortization expense $ 359,041

Deferral of Social Security Tax

Deferral of Social Security Tax Payments	9 Months Ended
	Sep. 30, 2022
Deferral Of Social Security Tax Payments
Deferral of Social Security Tax Payments	NOTE 4 – Deferral of Social Security Tax Payments Pursuant to sections 2302(a)(1) and (a)(2) of the CARES Act, the Company has elected to defer payments of its share of Social Security tax due during the “payroll tax deferral period.” The payroll tax deferral period began on March 27, 2020 and ended on December 31, 2020. At September 30, 2022, the total remaining amount of the deferral was $ 37,728 December 31, 2022

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders’ Equity	NOTE 5 - Stockholders’ Equity Common Stock On May 24, 2021, at a Special Stockholders Meeting, our stockholders approved an increase in the authorized shares of common stock from 12,000,000 24,000,000 In January 2021, the Company closed a public offering of its securities in which it issued 1,711,783 3.00 4,532,445 136,943 five years 3.75 In February 2021, the Company issued 263,200 In March 2021, the Company issued 119,000 250 19,000 191,204 21,591 In March 2021, the Company closed a public offering in which it issued 2,190,000 4.445 8,736,487 12,000,000 24,000,000 2,190,000 4.32 May 24, 2021 175,200 8 125 5.55625 8 In March 2021, Company issued 1,500 4.99 Preferred Stock The Company is authorized to issue 10,000,000 0.001 465 In January 2020, the Company entered into a Securities Purchase Agreement with certain institutional investors (the “Institutional Private Placement”), pursuant to which the Company issued and sold 1,640 1,000 9% 2.50 Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five-trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed At September 30, 2022, there were 132 87,267 Concurrent with the Institutional Private Placement, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued and sold to certain of its directors and the Company’s then largest stockholder 333 1,000 9% 48,544 At September 30, 2022, 333 61,651 Stock Options As of September 30, 2022, an aggregate of 450,617 In March 2022, the Company granted options to its non-employee directors to purchase up to an aggregate of 56,000 2.50 75% 25% During the nine months ended September 30, 2022, the Company granted twelve employees options to purchase up to an aggregate of 228,973 2.50 135,000 2.50 Also, during the nine months ended September 30, 2022, the Company granted two consultants options to purchase up to an aggregate of 14,000 2.50 The Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company’s stock on the grant date, The exercise prices will not be less than 100% of the fair market value of a share on the date of grant of the option. Stock options are typically granted throughout the year and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified. The Company recognizes compensation expense for the fair value of the stock options over the requisite service period for each stock option award. Total stock-based compensation expense included in the statements of operations for the nine months ended September 30, 2022 and 2021 was $ 613,833 893,431 The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the nine months ended September 30, 2022 and 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.95 3.23 % 0.19 0.70 % Expected volatility 106.40 109.97 % 116.8 123.8 % Expected life (in years) 5 5 Option activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Weighted Aggregate Options outstanding at December 31, 2020 713,010 5.15 4.40 477,802 Granted 698,831 3.29 4.39 46,800 Exercised (5,204 ) 2.50 - - Forfeited or cancelled (10,755 ) 3.49 - - Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 433,973 2.50 4.64 - Exercised - - - - Forfeited or cancelled (44,913 ) 4.21 - - Options outstanding September 30, 2022 1,784,942 3.82 3.50 - Options expected to vest in the future as of September 30, 2022 534,242 2.91 4.08 - Options exercisable at September 30, 2022 1,250,700 4.21 3.25 - Options vested, exercisable, and options expected to vest at September 30, 2022 1,784,942 3.82 3.50 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price below the 0.815 At September 30, 2022, there was $ 908,588 2.0 Stock Appreciation Rights On June 23, 2020, the board of directors (the “Board”) of the Company adopted the 2020 Stock Appreciation Rights Plan (the “Plan”). The purposes of the Plan are to: (i) enable the Company to attract and retain the types of employees, consultants, and directors (collectively, “Service Providers”) who will contribute to the Company’s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the stockholders of the Company; and (iii) promote the success of the Company’s business. The Plan provides for incentive awards only in the form of stock appreciation rights payable in cash (“SARs”) and no shares of common stock are reserved or will be issued pursuant to the Plan. SARs may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company’s common stock (“Share”) upon the exercise of the SAR. The “Spread” is the difference between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a share on the date of grant of the SAR. The administrator of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including, without limitation, the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant. During the nine months ended September 30, 2022, the Company granted a total of 404,975 1.30 2.50 Also, during the nine months ended September 30, 2022, the Company granted 406,887 1.30 2.50 30,000 194,940 181,947 On March 31, 2022, the Company granted 3,000 2.50 The Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period for each SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 “Compensation-Stock Compensation”, and any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date. The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the nine months ended September 30, 2022 and the year ended December 31, 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.82 2.79 % 0.39 0.40 % Expected volatility 108.38 119.02 % 123.0 % Expected life (in years) 5 5 SARs activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Weighted Aggregate - SARs outstanding at December 31, 2020 127,679 2.61 4.52 97,919 Granted 242,945 3.43 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 814,862 1.81 4.73 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding September 30, 2022 1,185,486 2.23 4.34 - SARs expected to vest in the future as of September 30, 2022 897,970 2.05 4.50 - SARs exercisable at September 30, 2022 287,516 2.80 3.84 - SARs vested, exercisable, and SARs expected to vest at September 30, 2022 1,185,486 2.23 4.34 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price below the 0.815 closing price of our common stock as reported on The Nasdaq Capital Market At September 30, 2022, there was $ 1,128,615 2.38 Warrants Warrant activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Warranty Activity Warrants Weighted Weighted Warrants outstanding at December 31, 2020 1,881,429 7.57 4.16 Granted 2,602,143 4.36 1.63 Exercised (495,641 ) 2.59 - Forfeited or cancelled - - - Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (162,150 ) 40.00 - Warrants outstanding at September 30, 2022 3,825,781 4.66 2.10

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 6 - Subsequent Events On October 14, 2022, the Company received notice from The Nasdaq Stock Market (“Nasdaq”) that the closing bid price for our common stock had been below $ 1.00 The Company believes that it will regain compliance with the $ 1.00 minimum bid price requirement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Nature of Business	Nature of Business
Basis of Presentation	Basis of Presentation
Reclassification	Reclassification
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company does not use derivative instruments for hedging of market risk or for trading or speculative purposes. On March 26, 2021, the Company issued warrants to purchase an aggregate of 2,190,000 May 24, 2021 12,000,000 24,000,000 May 24, 2023 Pursuant to ASC 815.40.25.10, such warrants were accounted for as a derivative liability because the Company did not have sufficient authorized and unissued shares of common stock available to settle the warrants at the issue date. On May 24, 2021, upon receiving stockholder approval to increase its authorized common shares, the Company reclassified the warrant liability to equity pursuant to ASC 815.40.35.8. For the nine months ended September 30, 2021, the Company recorded a gain of $ 1,092,441
Loss Per Share	Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share September 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,784,942 1,400,407 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,759,641 5,512,821 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2022 and 2021: Schedule of Computing Loss Per Share 2022 2021 2022 2021 Three Months Ended September 30 Nine Months Ended September 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.24 ) $ (0.65 ) $ (0.53 ) Loss Applicable to Common Stockholders (numerator) $ (2,306,528 ) $ (2,505,198 ) $ (6,789,533 ) $ (5,076,532 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,498,802 10,494,560 10,498,802 9,602,666
Accounting Estimates	Accounting Estimates
Revenue Recognition	Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers, pursuant to which it leases its PrintRite3D platform for terms between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment to which customers have the right to substantially all the economic benefit from and exclusive right to use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The leases may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months with 30-days written notice. Some, but not all, of the leases permit lessees to purchase the equipment at any time at an amount that approximates fair value and are not reasonably certain to be exercised at the inception of the lease. There are no anticipated variable lease payments at the inception of the lease. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training. The Company has elected the single component practical expedient to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training component does not have the same pattern of transfer; therefore, this component is not eligible for the single component practical expedient. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased equipment based on its useful life, and the ability to refurbish and sell the equipment, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from these operating leases for the three and nine months ended September 30, 2022 was $ 2,834 17,006 Minimum Lease Payments Receivable Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 8,503 2023 $ 8,503 2024 - 2025 and thereafter - Total $ 17,006 Equipment Underlying Operating Leases: Equipment under operating leases as of September 30, 2022 were comprised of the following: Schedule of Assets underlying Operating Leases September 30, PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 4,173 Net Book Value $ 34,776 The Company is depreciating the underlying equipment over its useful life of 7

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share September 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,784,942 1,400,407 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,759,641 5,512,821
Schedule of Computing Loss Per Share	The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2022 and 2021: Schedule of Computing Loss Per Share 2022 2021 2022 2021 Three Months Ended September 30 Nine Months Ended September 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.24 ) $ (0.65 ) $ (0.53 ) Loss Applicable to Common Stockholders (numerator) $ (2,306,528 ) $ (2,505,198 ) $ (6,789,533 ) $ (5,076,532 ) Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator) 10,498,802 10,494,560 10,498,802 9,602,666
Schedule of Minimum Lease Payments Receivable	Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 8,503 2023 $ 8,503 2024 - 2025 and thereafter - Total $ 17,006
Schedule of Assets underlying Operating Leases	Equipment under operating leases as of September 30, 2022 were comprised of the following: Schedule of Assets underlying Operating Leases September 30, PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 4,173 Net Book Value $ 34,776

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	At September 30, 2022 and December 31, 2021, the Company’s inventory was comprised of the following: Schedule of Inventory September 30, December 31, Raw Materials $ 264,558 $ 202,015 Work in Process 420,420 224,079 Finished Goods 282,454 283,986 Total Inventory $ 967,432 $ 710,080

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Definite-life Intangible Assets and Accumulated Amortization	The following is a summary of definite-life intangible assets less accumulated amortization as of September 30, 2022 and December 31, 2021, respectively: Summary of Definite-life Intangible Assets and Accumulated Amortization September 30, December 31, Provisional Patent Applications $ 725,164 $ 675,291 Patents 426,601 300,370 Less: Accumulated Amortization (67,560 ) (50,550 ) Net Intangible Assets $ 1,084,205 $ 925,111
Schedule of Aggregate Amortization Expense	The estimated aggregate amortization expense for each of the following years ending December 31 is as follows: Schedule of Aggregate Amortization Expense 2022 (Remaining) $ 6,153 2023 24,610 2024 24,610 2025 24,610 Thereafter 279,058 Intangible asset and amortization expense $ 359,041

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.95 3.23 % 0.19 0.70 % Expected volatility 106.40 109.97 % 116.8 123.8 % Expected life (in years) 5 5
Schedule of Stock Option Activity	Option activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Weighted Aggregate Options outstanding at December 31, 2020 713,010 5.15 4.40 477,802 Granted 698,831 3.29 4.39 46,800 Exercised (5,204 ) 2.50 - - Forfeited or cancelled (10,755 ) 3.49 - - Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 433,973 2.50 4.64 - Exercised - - - - Forfeited or cancelled (44,913 ) 4.21 - - Options outstanding September 30, 2022 1,784,942 3.82 3.50 - Options expected to vest in the future as of September 30, 2022 534,242 2.91 4.08 - Options exercisable at September 30, 2022 1,250,700 4.21 3.25 - Options vested, exercisable, and options expected to vest at September 30, 2022 1,784,942 3.82 3.50 -
Schedule of Warranty Activity	Warrant activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Warranty Activity Warrants Weighted Weighted Warrants outstanding at December 31, 2020 1,881,429 7.57 4.16 Granted 2,602,143 4.36 1.63 Exercised (495,641 ) 2.59 - Forfeited or cancelled - - - Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (162,150 ) 40.00 - Warrants outstanding at September 30, 2022 3,825,781 4.66 2.10
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the nine months ended September 30, 2022 and the year ended December 31, 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.82 2.79 % 0.39 0.40 % Expected volatility 108.38 119.02 % 123.0 % Expected life (in years) 5 5
Schedule of Stock Option Activity	SARs activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Weighted Aggregate - SARs outstanding at December 31, 2020 127,679 2.61 4.52 97,919 Granted 242,945 3.43 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 814,862 1.81 4.73 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding September 30, 2022 1,185,486 2.23 4.34 - SARs expected to vest in the future as of September 30, 2022 897,970 2.05 4.50 - SARs exercisable at September 30, 2022 287,516 2.80 3.84 - SARs vested, exercisable, and SARs expected to vest at September 30, 2022 1,185,486 2.23 4.34 -

Schedule of Antidilutive Securi

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	5,759,641	5,512,821
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	3,825,781	3,987,931
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	1,784,942	1,400,407
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	148,918	124,483

Schedule of Computing Loss Per

Schedule of Computing Loss Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accounting Policies [Abstract]
Net Loss per Common Share - Basic and Diluted	$ (0.22)	$ (0.24)	$ (0.65)	$ (0.53)
Loss Applicable to Common Stockholders (numerator)	$ (2,306,528)	$ (2,505,198)	$ (6,789,533)	$ (5,076,532)
Weighted Average Number of Common Shares Outstanding Used in Loss Per Share During the Period (denominator)	10,498,802	10,494,560	10,498,802	9,602,666

Schedule of Minimum Lease Payme

Schedule of Minimum Lease Payments Receivable (Details)	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
2022 (remaining)	$ 8,503
2023	8,503
2024
2025 and thereafter
Total	$ 17,006

Schedule of Assets underlying O

Schedule of Assets underlying Operating Leases (Details)	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
PrintRite 3D Hardware	$ 38,949
Accumulated Depreciation	4,173
Net Book Value	$ 34,776

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended	9 Months Ended
	Mar. 26, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	May 24, 2021	Mar. 31, 2021	Mar. 25, 2021	Jan. 31, 2021
Accounting Policies [Abstract]
Aggregate warrant purchase of shares	2,190,000								136,943
Warrants exercisable date	May 24, 2021
Common shares authorized	24,000,000	24,000,000	24,000,000		24,000,000	12,000,000	12,000,000	12,000,000
Expiration date	May 24, 2023
Derivative liability				$ 1,092,441
Lease income from operating leases		$ 2,834	$ 17,006
Underlying equipment useful life			7 years

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw Materials	$ 264,558	$ 202,015
Work in Process	420,420	224,079
Finished Goods	282,454	283,986
Total Inventory	$ 967,432	$ 710,080

Summary of Definite-life Intang

Summary of Definite-life Intangible Assets and Accumulated Amortization (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Less: Accumulated Amortization	$ (67,560)	$ (50,550)
Net Intangible Assets	1,084,205	925,111
Provisional Patent Applications [Member]
Finite-Lived Intangible Assets [Line Items]
Patents	725,164	675,291
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Patents	$ 426,601	$ 300,370

Schedule of Aggregate Amortizat

Schedule of Aggregate Amortization Expense (Details)	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (Remaining)	$ 6,153
2023	24,610
2024	24,610
2025	24,610
Thereafter	279,058
Intangible asset and amortization expense	$ 359,041

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization expense on intangible assets	$ 17,010	$ 22,998
Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Costs relate to patents issued	$ 126,231

Deferral of Social Security T_2

Deferral of Social Security Tax Payments (Details Narrative)	9 Months Ended
	Sep. 30, 2022 USD ($)
Deferral Of Social Security Tax Payments
Deferred Liabilities	$ 37,728
Tax credit carryforward, expiration ate	Dec. 31, 2022

Schedule of Share Based Payment

Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield	0%	0%
Risk-free interest rate, minimum	0.95%	0.19%
Risk-free interest rate, maximum	3.23%	0.70%
Expected volatility, minimum	106.40%	116.80%
Expected volatility, maximum	109.97%	123.80%
Expected life	5 years	5 years
2020 Stock Appreciation Rights Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield	0%		0%
Risk-free interest rate, minimum	0.82%		0.39%
Risk-free interest rate, maximum	2.79%		0.40%
Expected volatility, minimum	108.38%
Expected volatility, maximum	119.02%
Expected life	5 years		5 years
Expected volatility			123%

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	1,395,882	713,010
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 4.24	$ 5.15
Weighted Average Remaining Contractual Life, Outstanding Balance	3 years 6 months	3 years 10 months 20 days	4 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding Beginning Balance		$ 477,802
Number of Options, Granted	433,973	698,831
Weighted Average Exercise Price, Granted	$ 2.50	$ 3.29
Weighted Average Remaining Contractual Life, Granted	4 years 7 months 20 days	4 years 4 months 20 days
Aggregate Intrinsic Value, Granted		$ 46,800
Number of Options, Exercised		(5,204)
Weighted Average Exercise Price, Exercised		$ 2.50
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled	(44,913)	(10,755)
Weighted Average Exercise Price, Forfeited or cancelled	$ 4.21	$ 3.49
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding Ending Balance	1,784,942	1,395,882	713,010
Weighted Average Exercise Price, Outstanding Outstanding Balance	$ 3.82	$ 4.24	$ 5.15
Aggregate Intrinsic Value, Outstanding Beginning Balance			$ 477,802
Number of Options, Expected to vest in the future Ending Balance	534,242
Weighted Average Exercise Price, Expected to Vest	$ 2.91
Weighted Average Remaining Contractual Life, Expected to Vest	4 years 29 days
Aggregate Intrinsic Value, Outstanding, Expected of Vest
Number of Options, Exercisable	1,250,700
Weighted Average Exercise Price, Exercisable	$ 4.21
Weighted Average Remaining Contractual Life, Exercisable	3 years 3 months
Aggregate Intrinsic Value, Outstanding, Exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	1,784,942
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 3.82
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	3 years 6 months
Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest
Number of Options, Exercised		5,204
Number of Options, Forfeited or cancelled	44,913	10,755
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	370,624	127,679
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 3.15	$ 2.61
Weighted Average Remaining Contractual Life, Outstanding Balance	4 years 4 months 2 days	4 years 2 months 26 days	4 years 6 months 7 days
Aggregate Intrinsic Value, Outstanding Beginning Balance		$ 97,919
Number of Options, Granted	814,862	242,945
Weighted Average Exercise Price, Granted	$ 1.81	$ 3.43
Weighted Average Remaining Contractual Life, Granted	4 years 8 months 23 days	4 years 7 months 9 days
Aggregate Intrinsic Value, Granted
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled
Weighted Average Exercise Price, Forfeited or cancelled
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding Ending Balance	1,185,486	370,624	127,679
Weighted Average Exercise Price, Outstanding Outstanding Balance	$ 2.23	$ 3.15	$ 2.61
Aggregate Intrinsic Value, Outstanding Beginning Balance			$ 97,919
Number of Options, Expected to vest in the future Ending Balance	897,970
Weighted Average Exercise Price, Expected to Vest	$ 2.05
Weighted Average Remaining Contractual Life, Expected to Vest	4 years 6 months
Aggregate Intrinsic Value, Outstanding, Expected of Vest
Number of Options, Exercisable	287,516
Weighted Average Exercise Price, Exercisable	$ 2.80
Weighted Average Remaining Contractual Life, Exercisable	3 years 10 months 2 days
Aggregate Intrinsic Value, Outstanding, Exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	1,185,486
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 2.23
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	4 years 4 months 2 days
Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest
Number of Options, Exercised
Number of Options, Forfeited or cancelled

Schedule of Warranty Activity (

Schedule of Warranty Activity (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Warrants Outstanding, Beginning Balance	3,987,931	1,881,429
Weighted Average Exercise Price Outstanding, Beginning Balance	$ 6.10	$ 7.57
Weighted Average Remaining Contractual Life Years, Ending Balance	2 years 1 month 6 days	2 years 1 month 6 days	4 years 1 month 28 days
Warrants, Granted		2,602,143
Weighted Average Exercise Price Outstanding, Granted		$ 4.36
Weighted Average Remaining Contractual Life Years, Granted		1 year 7 months 17 days
Warrants,Exercised		(495,641)
Weighted Average Exercise Price Outstanding, Exercised		$ 2.59
Warrants, Forfeited or cancelled	(162,150)
Weighted Average Exercise Price Outstanding, Forfeited or cancelled	$ 40
Warrants Outstanding, Ending Balance	3,825,781	3,987,931	1,881,429
Weighted Average Exercise Price Outstanding,Ending Balance	$ 4.66	$ 6.10	$ 7.57

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative)			1 Months Ended					3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 02, 2022 shares	Mar. 26, 2021 shares	Mar. 31, 2022 $ / shares shares	Mar. 31, 2021 USD ($) $ / shares shares	Feb. 28, 2021 shares	Jan. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2020 $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares shares	May 24, 2021 shares	Mar. 25, 2021 shares
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized		24,000,000		12,000,000				24,000,000		24,000,000		24,000,000	12,000,000	12,000,000
Common stock issued during period						1,711,783
Share price per share | $ / shares						$ 3
Proceeds from public offering | $						$ 4,532,445
Warrants to purchase shares of common stock		2,190,000				136,943
Warrant term						5 years
Warrant exercise price | $ / shares						$ 3.75
Number of shares, warrants exercised												495,641
Warrants exercisable date		May 24, 2021
Preferred stock, shares authorized								10,000,000		10,000,000		10,000,000
Preferred stock, par value | $ / shares								$ 0.001		$ 0.001		$ 0.001
Preferred stock, shares issued								465		465		465
Preferred stock, shares outstanding								465		465		465
Number of shares granted										433,973		698,831
Allocation share based compensation expense | $								$ 275,418	$ 659,512	$ 613,833	$ 893,431
Option exercise price | $ / shares										$ 0.815
Stock options compensation cost | $								$ 908,588		$ 908,588
Weighted average remaining recognition period										2 years
Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted			56,000
Option strike price | $ / shares			$ 2.50					$ 2.50		$ 2.50
Vesting percentage										75%
Directors [Member] | December 31, 2022 [Member]
Subsidiary, Sale of Stock [Line Items]
Vesting percentage										25%
Twelve Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted										228,973
President and CEO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted										135,000
Option strike price | $ / shares								2.50		$ 2.50
Common shares granted for the period	194,940		30,000							406,887
President and CEO [Member] | Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares										$ 1.30
President and CEO [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares										$ 2.50
President and CEO [Member] | March 15, 2025 [Member]
Subsidiary, Sale of Stock [Line Items]
Common shares granted for the period										181,947
Two Consultants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted										14,000
Option strike price | $ / shares								$ 2.50		$ 2.50
Fifteen Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Common shares granted for the period										404,975
Fifteen Employees [Member] | Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares										$ 1.30
Fifteen Employees [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares										$ 2.50
Consultant [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares			$ 2.50
Common shares granted for the period			3,000
2013 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock shares reserved for issuance								450,617		450,617
2020 Stock Appreciation Rights Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Option exercise price | $ / shares										$ 0.815
Unrecognized share based compensation cost | $								$ 1,128,615		$ 1,128,615
Weighted average remaining recognition period										2 years 4 months 17 days
Investor [Member]
Subsidiary, Sale of Stock [Line Items]
Share price per share | $ / shares				$ 4.99
Stock issued during the period, service rendered				1,500
April 2020 Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period				21,591
Number of shares, warrants exercised				191,204
Placement Agent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock				175,200
Warrant exercise price | $ / shares				$ 5.55625
Percentage of warrant exercise price				8
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of warrant exercise price				125
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period											3,901,783
Stock issued during the period, service rendered											1,500
Series D Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period				119,000
Conversion of stock shares converted				250
Number of shares as in-kind payment, shares				19,000
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period										87,267
Preferred stock, par value | $ / shares							$ 1,000
Preferred stock, shares outstanding								132		132
Sale of shares							1,640
Dividend percentage							9%
Conversion price per share | $ / shares							$ 2.50
Conversion description							Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five-trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed
Series E Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period										61,651
Conversion of stock shares converted										48,544
Preferred stock, par value | $ / shares								$ 1,000		$ 1,000
Preferred stock, shares outstanding								333		333
Sale of shares										333
Dividend percentage										9%
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period					263,200
Private Placement [Member] | Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock				2,190,000
Warrant exercise price | $ / shares				$ 4.32
Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period				2,190,000
Share price per share | $ / shares				$ 4.445
Proceeds from public offering | $				$ 8,736,487

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Oct. 14, 2022 $ / shares
Subsequent Event [Member]
Subsequent Event [Line Items]
Minimum bid price per share	$ 1